Antagonism of the protein kinase R pathway by the guinea pig cytomegalovirus US22-family gene gp145

Virology

Volumn 433, Issue 1, 2012, Pages 157-166

  Bierle, Craig J ^a,b   Schleiss, Mark R ^c,d   Geballe, Adam P ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d Pediatric Infectious Diseases   (United States)

Author keywords

Cytomegalovirus; Double stranded RNA; EIF2 ; Gp145; Guinea pig; Protein kinase R; TRS1; US22 gene family

Indexed keywords

DOUBLE STRANDED RNA; PROTEIN GP145; PROTEIN KINASE R; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENZYME BINDING; ENZYME INHIBITION; FUNCTIONAL PROTEOMICS; GENE EXPRESSION REGULATION; GENE MAPPING; GENETIC TRANSFECTION; GP145 GENE; GUINEA PIG CYTOMEGALOVIRUS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN RNA BINDING; REPORTER GENE; VACCINIA VIRUS; VIRUS GENE; VIRUS MUTANT; VIRUS REPLICATION;

ANIMALS; EIF-2 KINASE; EUKARYOTIC INITIATION FACTOR-2; GENES, REPORTER; GUINEA PIGS; HUMANS; MICE; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RNA, DOUBLE-STRANDED; RNA-BINDING PROTEINS; ROSEOLOVIRUS; SIGNAL TRANSDUCTION; TRANSFECTION; VACCINIA VIRUS; VIRAL PROTEINS; VIRUS REPLICATION;

CAVIA; CYTOMEGALOVIRUS; GUINEA PIG CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; MURINAE; PRIMATES; RODENTIA; VACCINIA VIRUS;

EID: 84866167299     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.08.005     Document Type: Article

References (59)

1. Adamo J.E., Schroer J., Shenk T. Human cytomegalovirus TRS1 protein is required for efficient assembly of DNA-containing capsids. J. Virol. 2004, 78(19):10221-10229.
2. Barry P.A., Lockridge K.M., Salamat S., Tinling S.P., Yue Y., Zhou S.S., Gospe S.M., Britt W.J., Tarantal A.F. Nonhuman primate models of intrauterine cytomegalovirus infection. ILAR J. 2006, 47(1):49-64.
3. Bate S.L., Dollard S.C., Cannon M.J. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 2010, 50(11):1439-1447.
4. Beattie E., Denzler K.L., Tartaglia J., Perkus M.E., Paoletti E., Jacobs B.L. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J. Virol. 1995, 69(1):499-505.
5. Beattie E., Kauffman E.B., Martinez H., Perkus M.E., Jacobs B.L., Paoletti E., Tartaglia J. Host-range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes 1996, 12(1):89-94.
6. Beattie E., Tartaglia J., Paoletti E. Vaccinia virus-encoded eIF-2 alpha homolog abrogates the antiviral effect of interferon. Virology 1991, 183(1):419-422.
7. Buaas F.W., Lee K., Edelhoff S., Disteche C., Braun R.E. Cloning and characterization of the mouse interleukin enhancer binding factor 3 (Ilf3) homolog in a screen for RNA binding proteins. Mamm. Genome 1999, 10(5):451-456.
8. Budt M., Niederstadt L., Valchanova R.S., Jonjic S., Brune W. Specific inhibition of the PKR-mediated antiviral response by the murine cytomegalovirus proteins m142 and m143. J. Virol. 2009, 83(3):1260-1270.
9. Chang H.W., Watson J.C., Jacobs B.L. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. U S A 1992, 89(11):4825-4829.
10. Chaumorcel M., Lussignol M., Mouna L., Cavignac Y., Fahie K., Cotte-Laffitte J., Geballe A., Brune W., Beau I., Codogno P., Esclatine A. The human cytomegalovirus protein TRS1 inhibits autophagy via its interaction with Beclin 1. J. Virol. 2012, 86(5):2571-2584.
11. Chee M.S., Bankier A.T., Beck S., Bohni R., Brown C.M., Cerny R., Horsnell T., Hutchison C.A., Kouzarides T., Martignetti J.A., et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 1990, 154:125-169.
12. Child S.J., Brennan G., Braggin J.E., Geballe A.P. Species specificity of protein kinase R antagonism by cytomegalovirus TRS1 genes. J. Virol. 2012, 86(7):3880-3889.
13. Child S.J., Geballe A.P. Binding and relocalization of protein kinase R by murine cytomegalovirus. J. Virol. 2009, 83(4):1790-1799.
14. Child S.J., Hakki M., De Niro K.L., Geballe A.P. Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J. Virol. 2004, 78(1):197-205.
15. Child S.J., Hanson L.K., Brown C.E., Janzen D.M., Geballe A.P. Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins. J. Virol. 2006, 80(20):10173-10180.
16. Child S.J., Jarrahian S., Harper V.M., Geballe A.P. Complementation of vaccinia virus lacking the double-stranded RNA-binding protein gene E3L by human cytomegalovirus. J. Virol. 2002, 76(10):4912-4918.
17. Craig R., Beavis R.C. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004, 20(9):1466-1467.
18. Cui X., McGregor A., Schleiss M.R., McVoy M.A. The impact of genome length on replication and genome stability of the herpesvirus guinea pig cytomegalovirus. Virology 2009, 386(1):132-138.
19. Davies M.V., Chang H.W., Jacobs B.L., Kaufman R.J. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J. Virol. 1993, 67(3):1688-1692.
20. Demmler G.J. Congenital cytomegalovirus infection and disease. Adv. Pediatr. Infect. Dis. 1996, 11:135-162.
21. Elde N.C., Child S.J., Geballe A.P., Malik H.S. Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 2009, 457(7228):485-489.
22. Garcia M.A., Gil J., Ventoso I., Guerra S., Domingo E., Rivas C., Esteban M. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 2006, 70(4):1032-1060.
23. Geballe A.P., Mocarski E.S. Translational control of cytomegalovirus gene expression is mediated by upstream AUG codons. J. Virol. 1988, 62(9):3334-3340.
24. Hakki M., Geballe A.P. Double-stranded RNA binding by human cytomegalovirus pTRS1. J. Virol. 2005, 79(12):7311-7318.
25. Hakki M., Marshall E.E., De Niro K.L., Geballe A.P. Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1. J. Virol. 2006, 80(23):11817-11826.
26. Hansen S.G., Strelow L.I., Franchi D.C., Anders D.G., Wong S.W. Complete sequence and genomic analysis of rhesus cytomegalovirus. J. Virol. 2003, 77(12):6620-6636.
27. Jacobs B.L., Langland J.O., Brandt T. Characterization of viral double-stranded RNA-binding proteins. Methods 1998, 15(3):225-232.
28. Janzen D.M., Geballe A.P. The effect of eukaryotic release factor depletion on translation termination in human cell lines. Nucleic Acids Res. 2004, 32(15):4491-4502.
29. Jentarra G.M., Heck M.C., Youn J.W., Kibler K., Langland J.O., Baskin C.R., Ananieva O., Chang Y., Jacobs B.L. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination. Vaccine 2008, 26(23):2860-2872.
30. Langland J.O., Cameron J.M., Heck M.C., Jancovich J.K., Jacobs B.L. Inhibition of PKR by RNA and DNA viruses. Virus Res. 2006, 119(1):100-110.
31. Langland J.O., Pettiford S.M., Jacobs B.L. Nucleic acid affinity chromatography: preparation and characterization of double-stranded RNA agarose. Protein Expr. Purif. 1995, 6(1):25-32.
32. Licklider L.J., Thoreen C.C., Peng J., Gygi S.P. Automation of nanoscale microcapillary liquid chromatography-tandem mass spectrometry with a vented column. Anal. Chem. 2002, 74(13):3076-3083.
33. Marshall E.E., Bierle C.J., Brune W., Geballe A.P. Essential role for either TRS1 or IRS1 in human cytomegalovirus replication. J. Virol. 2009, 83(9):4112-4120.
34. McGeoch D.J., Rixon F.J., Davison A.J. Topics in herpesvirus genomics and evolution. Virus Res. 2006, 117(1):90-104.
35. Menard C., Wagner M., Ruzsics Z., Holak K., Brune W., Campbell A.E., Koszinowski U.H. Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J. Virol. 2003, 77(10):5557-5570.
36. Meredith R.W., Janecka J.E., Gatesy J., Ryder O.A., Fisher C.A., Teeling E.C., Goodbla A., Eizirik E., Simao T.L., Stadler T., Rabosky D.L., Honeycutt R.L., Flynn J.J., Ingram C.M., Steiner C., Williams T.L., Robinson T.J., Burk-Herrick A., Westerman M., Ayoub N.A., Springer M.S., Murphy W.J. Impacts of the Cretaceous Terrestrial Revolution and KPg extinction on mammal diversification. Science 2011, 334(6055):521-524.
37. Mohr I., Gluzman Y. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J. 1996, 15(17):4759-4766.
38. Mohr I., Pe'ery T., Mathews M.B. Protein synthesis and translational control during viral infection. Translational Control in Biology and Medicine 2007, 545-599. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 3rd ed. M.B. Mathews, N. Sonenberg, J.W.B. Hershey (Eds.).
39. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75(17):4646-4658.
40. Nozawa N., Yamamoto Y., Fukui Y., Katano H., Tsutsui Y., Sato Y., Yamada S., Inami Y., Nakamura K., Yokoi M., Kurane I., Inoue N. Identification of a 1.6kb genome locus of guinea pig cytomegalovirus required for efficient viral growth in animals but not in cell culture. Virology 2008, 379(1):45-54.
41. Pari G.S., Kacica M.A., Anders D.G. Open reading frames UL44, IRS1/TRS1, and UL36-38 are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA synthesis. J. Virol. 1993, 67(5):2575-2582.
42. Perdiguero B., Esteban M. The interferon system and vaccinia virus evasion mechanisms. J. Interferon Cytokine Res. 2009, 29(9):581-598.
43. Poppers J., Mulvey M., Perez C., Khoo D., Mohr I Identification of a lytic-cycle Epstein-Barr virus gene product that can regulate PKR activation. J. Virol. 2003, 77(1):228-236.
44. Powers C., Fruh K. Rhesus CMV: an emerging animal model for human CMV. Med. Microbiol. Immunol. 2008, 197(2):109-115.
45. Ramos A., Grunert S., Adams J., Micklem D.R., Proctor M.R., Freund S., Bycroft M., Johnston D., Varani G. RNA recognition by a Staufen double-stranded RNA-binding domain. EMBO J. 2000, 19(5):997-1009.
46. Rauch A., Bellew M., Eng J., Fitzgibbon M., Holzman T., Hussey P., Igra M., Maclean B., Lin C.W., Detter A., Fang R., Faca V., Gafken P., Zhang H., Whiteaker J., States D., Hanash S., Paulovich A., McIntosh M.W Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. J. Proteome Res. 2006, 5(1):112-121.
47. Rawlinson W.D., Farrell H.E., Barrell B.G. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 1996, 70(12):8833-8849.
48. Romanowski M.J., Shenk T. Characterization of the human cytomegalovirus irs1 and trs1 genes: a second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation. J. Virol. 1997, 71(2):1485-1496.
49. Rothenburg S., Seo E.J., Gibbs J.S., Dever T.E., Dittmar K. Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors. Nat. Struct. Mol. Biol. 2009, 16(1):63-70.
50. Schleiss M.R. Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns. ILAR J. 2006, 47(1):65-72.
51. Schleiss M.R., McGregor A., Choi K.Y., Date S.V., Cui X., McVoy M.A. Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome. Virol. J. 2008, 5:139.
52. Shors T., Kibler K.V., Perkins K.B., Seidler-Wulff R., Banaszak M.P., Jacobs B.L. Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L. Virology 1997, 239(2):269-276.
53. Stasiak P.C., Mocarski E.S. Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J. Virol. 1992, 66(2):1050-1058.
54. Strang B.L., Geballe A.P., Coen D.M. Association of human cytomegalovirus proteins IRS1 and TRS1 with the viral DNA polymerase accessory subunit UL44. J. Gen. Virol. 2010, 91(Pt 9):2167-2175.
55. Valchanova R.S., Picard-Maureau M., Budt M., Brune W. Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis. J. Virol. 2006, 80(20):10181-10190.
56. Weber F., Wagner V., Rasmussen S.B., Hartmann R., Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 2006, 80(10):5059-5064.
57. Weston K., Barrell B.G. Sequence of the short unique region, short repeats, and part of the long repeats of human cytomegalovirus. J. Mol. Biol. 1986, 192(2):177-208.
58. Zhang D., Iyer L.M., Aravind L. A novel immunity system for bacterial nucleic acid degrading toxins and its recruitment in various eukaryotic and DNA viral systems. Nucleic Acids Res. 2011, 39(11):4532-4552.
59. Zhang P., Samuel C.E. Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells. J. Virol. 2007, 81(15):8192-8200.